• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. OPTIPAC-S 60 REFOBACIN BONE CEMENT R; BONE CEMENT, ANTIBIOTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. OPTIPAC-S 60 REFOBACIN BONE CEMENT R; BONE CEMENT, ANTIBIOTIC Back to Search Results
Model Number N/A
Device Problem Improper Flow or Infusion (2954)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 01/09/2019
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Report source: foreign - event occurred in (b)(6).Customer has indicated that the product is in process of being returned to zimmer biomet for investigation.Once the investigation has been completed, a follow-up mdr will be submitted.
 
Event Description
It was reported that monomer was not entering.
 
Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional information.The following section has been updated : b5, d1, e1, g1-2, g4, h2, h3, h6, h10.The reported event could not be confirmed.The device was not returned to the manufacturer.Therefore it could not be analyzed.The review of the device manufacturing quality record indicates that (b)(4) products optipac-s 60 refobacin bone cement r, reference 4711500396-1, lot number a714b06385 were manufactured on 18 april 2017.The device manufacturing quality record indicates that the released product met all requirements to perform as intended.No non conformity or deviation was observed which could be linked to the event described in the complaint.1 complaint has been recorded for optipac-s 60 refobacin bone cement r, reference 4711500396-1, batch a714b06385 on the reported event within one year.With the available information, the exact root cause of the event could not be determined.An investigation has been performed, consisting of a documentary review.The documentary review showed that product was manufactured according to the pre-defined specifications of biomet france.The product analysis can't be performed as the product was not returned.According to available data, the exact root cause can¿t be determined.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
It was reported that monomer was not entering.No adverse event has been reported as a result of the malfunction.
 
Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional information.The following section has been updated : e1, h2, h3, h6, h10.The involved product was received and analyzed.During the product analysis, it was noticed that the returned product was an optipac with two pouches.The left pouch was partially empty and the other was totally empty.Both of the left and right cylinder cannula were obstructed.Therefore, the product analysis permitted to confirm the reported event.The review of the device manufacturing quality record indicates that 1912 products optipac-s 60 refobacin bone cement r, reference (b)(4), lot number a714b06385 were manufactured on 18 april 2017.The device manufacturing quality record indicates that the released product met all requirements to perform as intended.No non conformity or deviation was observed which could be linked to the event described in the complaint.1 complaint has been recorded for optipac-s 60 refobacin bone cement r, reference (b)(4), batch a714b06385 on the reported event within one year.According to available data, the exact root cause could not be determined.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
It was reported that monomer was not entering.No adverse event has been reported as a result of the malfunction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIPAC-S 60 REFOBACIN BONE CEMENT R
Type of Device
BONE CEMENT, ANTIBIOTIC
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
MDR Report Key8329505
MDR Text Key138557475
Report Number3006946279-2019-00113
Device Sequence Number1
Product Code MBB
UDI-Device Identifier03599870112229
UDI-Public(01)03599870112229
Combination Product (y/n)N
PMA/PMN Number
K150850
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup,Followup
Report Date 02/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/11/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2018
Device Model NumberN/A
Device Catalogue Number4711500396-1
Device Lot NumberA714B06385
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received02/17/2020
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberN/A
Patient Sequence Number1
-
-